60 Participants Needed

MIND Diet for Breast Cancer

(MIND-TNBC Trial)

Recruiting at 1 trial location
TO
Overseen ByThe Ohio State University Comprehensive Cancer Center
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Ohio State University Comprehensive Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial examines whether a specific healthy eating plan, the MIND diet (Mediterranean-DASH Intervention for Neurodegenerative Delay), can reduce "chemobrain" and other symptoms like fatigue and anxiety in women with stage II-III triple-negative breast cancer undergoing chemotherapy. Participants will be divided into two groups: one will follow the MIND diet, while the other will receive general health advice, with an opportunity to try the MIND diet later. This trial may suit women recently diagnosed with this type of breast cancer who are about to start or have recently started chemotherapy and can access the internet for virtual sessions. As an unphased trial, it offers a unique opportunity to explore the potential benefits of the MIND diet for improving quality of life during chemotherapy.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It focuses on diet and does not mention medication changes.

Is there any evidence suggesting that the MIND eating plan is safe for women with breast cancer?

Research has shown that the MIND eating plan, which combines elements of the Mediterranean and DASH diets, is generally safe and easy to follow. This diet emphasizes nutritious, plant-based foods like leafy greens, nuts, and berries. Studies have found that people who adhere to this diet have a significantly lower risk of developing breast cancer.

The MIND diet has also been used in other studies to enhance brain health without causing major side effects. This suggests it could be a safe option for those looking to reduce memory and thinking problems related to cancer treatment. Although specific information on side effects from these studies is limited, the diet's focus on healthy foods supports its safety.12345

Why are researchers excited about this trial?

Researchers are excited about the MIND Eating Plan for breast cancer because it takes a unique approach by focusing on dietary habits rather than traditional medical treatments like chemotherapy or hormone therapy. The MIND diet combines aspects of the Mediterranean and DASH diets, emphasizing foods that may support brain health and reduce inflammation, which could have potential benefits for cancer patients. Unlike conventional treatments, this plan offers a non-invasive option that integrates lifestyle changes, allowing patients to take an active role in their treatment and potentially improving overall well-being. Additionally, the use of wearable technology like Fitbits helps track physical activity, providing valuable data on how lifestyle modifications impact health outcomes.

What evidence suggests that the MIND eating plan might be an effective treatment for cancer-related cognitive impairment?

Research has shown that the MIND diet, which combines elements of the Mediterranean and DASH diets, may slow memory and thinking problems. Studies have found that people who follow the MIND diet tend to experience fewer memory and thinking issues as they age. Additionally, women who adhere to the MIND diet are less likely to develop breast cancer. This trial will compare two groups: one group will receive MIND diet counseling, focusing on nutritious, plant-based foods like leafy greens, nuts, and berries, which benefit brain health. The other group will receive general health recommendations. These findings suggest that the MIND diet may improve mental function and reduce "chemobrain" symptoms in women undergoing breast cancer treatment.12367

Who Is on the Research Team?

TO

Tonya Orchard, PhD

Principal Investigator

Ohio State University Comprehensive Cancer Center

Are You a Good Fit for This Trial?

This trial is for women aged 40-65 with newly diagnosed stage II-III triple negative breast cancer, who are about to start or have started chemotherapy within the last 6 months. Participants must be able to use internet resources and video calls for remote sessions.

Inclusion Criteria

I am between 40 and 65 years old.
Ability to access and use internet resources, including video calls using Zoom platform
English speaking
See 2 more

Exclusion Criteria

Current healthy eating pattern reflected by high MIND diet score (e.g. > 8)
Unwilling/unable to eat > 2 types of MIND food (e.g. avoids > 2 categories or food groups such as leafy greens, olive oil and non-fried fish)
Currently pregnant
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either MIND diet counseling or general health recommendations over 12 weeks, with virtual sessions and dietary interventions.

12 weeks
8 virtual sessions

Follow-up

Participants are monitored for sustainability of dietary changes and outcome measures 6 months post-intervention.

6 months

Open-label extension (optional)

Participants initially in the general health recommendations group may opt into the MIND diet intervention after the 6-month follow-up.

What Are the Treatments Tested in This Trial?

Interventions

  • MIND Eating Plan
Trial Overview The study tests if the MIND eating plan can reduce 'chemobrain' and other symptoms like fatigue, sleep issues, anxiety, and depression during chemotherapy. It compares this diet with general health coaching over a period of 12 weeks with follow-up after six months.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (MIND-TNBC counseling)Experimental Treatment5 Interventions
Group II: Arm II (general health recommendations counseling)Active Control5 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Ohio State University Comprehensive Cancer Center

Lead Sponsor

Trials
350
Recruited
295,000+

American Institute for Cancer Research

Collaborator

Trials
12
Recruited
8,600+

Published Research Related to This Trial

In a 3-year randomized controlled trial involving 604 older adults at risk for dementia, the MIND diet did not show significant cognitive benefits compared to a control diet, with only a slight improvement in global cognition scores for the MIND diet group.
MRI results indicated no significant differences in brain characteristics, such as white-matter hyperintensities and hippocampal volumes, between participants following the MIND diet and those on the control diet.
Trial of the MIND Diet for Prevention of Cognitive Decline in Older Persons.Barnes, LL., Dhana, K., Liu, X., et al.[2023]
In a study of 350 women with breast cancer and 700 healthy controls, those who adhered closely to the MIND diet had a 60% lower risk of developing breast cancer compared to those with the lowest adherence.
Postmenopausal women and normal-weight women who followed the MIND diet also showed significantly reduced odds of breast cancer, suggesting that this dietary pattern may be protective against the disease.
Adherence to the MIND Diet and Risk of Breast Cancer: A Case-control Study.Aghamohammadi, V., Salari-Moghaddam, A., Benisi-Kohansal, S., et al.[2021]
In a study of 339 individuals with obesity, those who adhered more closely to the MIND diet showed lower levels of stress and higher insulin sensitivity, suggesting potential mental health and metabolic benefits.
The highest MIND diet scores were linked to increased intake of brain-healthy foods and a significant reduction in the consumption of unhealthy sweets and pastries, indicating a positive dietary shift.
Evaluating the association between the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet, mental health, and cardio-metabolic risk factors among individuals with obesity.Ardekani, AM., Vahdat, S., Hojati, A., et al.[2023]

Citations

The MIND-BC Study: MIND Diet for Breast Cancer Cognitiona combination of the Mediterranean and DASH diets emphasizing consumption of high-nutrient, plant-based foods such as green leafy vegetables, nuts, berries, ...
MIND Dietary Intervention to Prevent Cognitive Changes in ...Data has shown that following the MIND diet pattern may slow the rate of cognitive decline. The MIND diet intervention may prevent cognitive changes in women ...
Adherence to the MIND Diet and Risk of Breast CancerAfter adjustment for age and energy intake, women in the top tertile of the MIND diet score had 60% lower odds of breast cancer than women in the bottom tertile ...
Mediterranean-DASH Intervention for Neurodegenerative ...The MIND study is a randomized controlled intervention trial designed to compare the effects of the MIND diet with mild weight loss, versus participants' usual ...
The relationship between Mediterranean- DASH diet ...Recently, a new index called Mediterranean-DASH diet intervention for the neurodegenerative delay (MIND) diet has been developed using the related components of ...
Trial of the MIND Diet for Prevention of Cognitive Decline in ...In a trial of the MIND diet that was designed to improve brain health, cognitive function and brain imaging outcomes at 3 years did not differ ...
The association of the MIND diet and its components with ...This was a cross-sectional study of 30 post-menopausal breast cancer survivors within one year of completing chemotherapy; 21 had complete data ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity